Glycosaminoglycan neutralization in coagulation control

AIS Sobczak, SJ Pitt, AJ Stewart - Arteriosclerosis, thrombosis, and …, 2018 - Am Heart Assoc
The glycosaminoglycans (GAGs) heparan sulfate, dermatan sulfate, and heparin are
important anticoagulants that inhibit clot formation through interactions with antithrombin and …

Chemistry and biology of glycosaminoglycans in blood coagulation

R Barbucci, A Magnani, S Lamponi… - Polymers for …, 1996 - Wiley Online Library
Glycosaminoglycans (GAGs) are widely distributed in animal tissues where they are usually
associated with proteins. Six types are commonly recognized: heparin (Hep), heparan …

[HTML][HTML] New applications of heparin and other glycosaminoglycans

M Lima, T Rudd, E Yates - Molecules, 2017 - mdpi.com
Heparin, the widely used pharmaceutical anticoagulant, has been in clinical use for well
over half a century. Its introduction reduced clotting risks substantially and subsequent …

Control of the coagulation system by serpins: getting by with a little help from glycosaminoglycans

RN Pike, AM Buckle, BF le Bonniec… - The FEBS …, 2005 - Wiley Online Library
Members of the serine protease inhibitor (serpin) superfamily play important roles in the
inhibition of serine proteases involved in complex systems. This is evident in the regulation …

[HTML][HTML] Mechanisms of glycosaminoglycan activation of the serpins in hemostasis

JA Huntington - Journal of Thrombosis and Haemostasis, 2003 - Elsevier
Serpins are the predominant protease inhibitors in the higher organisms and are
responsible, in humans, for the control of many highly regulated processes including blood …

[HTML][HTML] Antithrombin-mediated anticoagulant activity of sulfated polysaccharides: different mechanisms for heparin and sulfated galactans

FR Melo, MS Pereira, D Foguel, PAS Mourao - Journal of Biological …, 2004 - ASBMB
We investigated the mechanisms of anticoagulant activity mediated by sulfated galactans.
The anticoagulant activity of sulfated polysaccharides is achieved mainly through …

More to “heparin” than anticoagulation

U Lindahl, K Lidholt, D Spillmann, L Kjellén - Thrombosis research, 1994 - Elsevier
Heparin and HS are glycosaminoglycans (GAGS), and are synthesized as proteoglycans in
which the GAG chains are covalently bound to serine residues of core proteins. GAGS are …

Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins

P Bendayan, H Boccalon, D Dupouy… - Thrombosis and …, 1994 - thieme-connect.com
Clot-bound thrombin proteolyses fibrinogen and amplifies the coagulation cascade at its
close vicinity, thereby ensuring the growth of fibrin-rich thrombus. The present study …

Heparin binds to human monocytes and modulates their procoagulant activities and secretory phenotypes. Effects of histidine-rich glycoprotein

L Leung, K Saigo, D Grant - 1989 - ashpublications.org
The binding of heparin to human monocytes and the monocytoid cell line U937 was
characterized. Heparin binding was rapid, specific, saturable, and reversible. There was a …

The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide

DM Tollefsen - Heparin and Related Polysaccharides, 1992 - Springer
The anticoagulant activities of glycosaminoglycans are mediated by antithrombin III (ATIII)
and heparin cofactor II (HCII), members of the “serpin” family that are present in plasma at …